BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12874391)

  • 1. Potassium channels, the cerebellum, and treatment for downbeat nystagmus.
    Leigh RJ
    Neurology; 2003 Jul; 61(2):158-9. PubMed ID: 12874391
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of 3,4-diaminopyridine on the gravity dependence of ocular drift in downbeat nystagmus.
    Helmchen C; Sprenger A; Rambold H; Sander T; Kömpf D; Straumann D
    Neurology; 2004 Aug; 63(4):752-3. PubMed ID: 15326263
    [No Abstract]   [Full Text] [Related]  

  • 3. Upbeat about downbeat nystagmus.
    Halmagyi GM; Leigh RJ
    Neurology; 2004 Aug; 63(4):606-7. PubMed ID: 15326227
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
    Strupp M; Schüler O; Krafczyk S; Jahn K; Schautzer F; Büttner U; Brandt T
    Neurology; 2003 Jul; 61(2):165-70. PubMed ID: 12874393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 3,4-diaminopyridine on the postural control in patients with downbeat nystagmus.
    Sprenger A; Zils E; Rambold H; Sander T; Helmchen C
    Ann N Y Acad Sci; 2005 Apr; 1039():395-403. PubMed ID: 15826992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain.
    Kalla R; Glasauer S; Schautzer F; Lehnen N; Büttner U; Strupp M; Brandt T
    Neurology; 2004 Apr; 62(7):1228-9. PubMed ID: 15079036
    [No Abstract]   [Full Text] [Related]  

  • 7. 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.
    Kalla R; Glasauer S; Büttner U; Brandt T; Strupp M
    Brain; 2007 Sep; 130(Pt 9):2441-51. PubMed ID: 17664175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of 3,4-diaminopyridine on positioning downbeat nystagmus in a circumscribed uvulo-nodular lesion.
    Helmchen C; Gottschalk S; Sander T; Trillenberg P; Rambold H; Sprenger A
    J Neurol; 2007 Aug; 254(8):1126-8. PubMed ID: 17410325
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of regularity and synchrony of cerebellar Purkinje cells for pathological nystagmus.
    Glasauer S; Rössert C; Strupp M
    Ann N Y Acad Sci; 2011 Sep; 1233():162-7. PubMed ID: 21950989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 4-aminopyridine on nystagmus and vestibulo-ocular reflex in ataxia-telangiectasia.
    Shaikh AG; Marti S; Tarnutzer AA; Palla A; Crawford TO; Zee DS; Straumann D
    J Neurol; 2013 Nov; 260(11):2728-35. PubMed ID: 23884713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-aminopyridine restores visual ocular motor function in upbeat nystagmus.
    Glasauer S; Kalla R; Büttner U; Strupp M; Brandt T
    J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):451-3. PubMed ID: 15716550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical use of 4-aminopyridine in patients with downbeat nystagmus.
    Domínguez-Durán E; Mármol-Szombathy I; Baños-Roldán Ú; Sánchez-Gómez S
    Acta Otorrinolaringol Esp (Engl Ed); 2020; 71(1):40-44. PubMed ID: 31078225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine.
    Strupp M; Kalla R; Dichgans M; Freilinger T; Glasauer S; Brandt T
    Neurology; 2004 May; 62(9):1623-5. PubMed ID: 15136697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus.
    Kalla R; Spiegel R; Claassen J; Bardins S; Hahn A; Schneider E; Rettinger N; Glasauer S; Brandt T; Strupp M
    J Neuroophthalmol; 2011 Dec; 31(4):320-5. PubMed ID: 21734596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Aminopyridine suppresses positional nystagmus caused by cerebellar vermis lesion.
    Kremmyda O; Zwergal A; la Fougère C; Brandt T; Jahn K; Strupp M
    J Neurol; 2013 Jan; 260(1):321-3. PubMed ID: 23180177
    [No Abstract]   [Full Text] [Related]  

  • 16. 18F-fluorodeoxyglucose hypometabolism in cerebellar tonsil and flocculus in downbeat nystagmus.
    Bense S; Best C; Buchholz HG; Wiener V; Schreckenberger M; Bartenstein P; Dieterich M
    Neuroreport; 2006 Apr; 17(6):599-603. PubMed ID: 16603919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacotherapy of central oculomotor disorders].
    Kalla R; Spiegel R; Wagner J; Rettinger N; Jahn K; Strupp M
    Nervenarzt; 2008 Dec; 79(12):1377-8, 1380-2, 1384-5. PubMed ID: 18633586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminopyridine treatment in a patient with bilateral vestibular failure and cryptogenic downbeat nystagmus.
    Spiegel R; Kalla R; Classen J; Bardins S; Anciães da Silva F; Farahmand P; Hahn A; Schneider E; Rettinger N; Jahn K; Brandt T; Strupp M
    J Neuroophthalmol; 2012 Jun; 32(2):190. PubMed ID: 22487785
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.
    Hess E
    Neurology; 2011 Nov; 77(22):1996-7; author reply 1997. PubMed ID: 22123782
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological treatment of nystagmus].
    Pieh-Beisse C; Lagrèze WA
    Ophthalmologe; 2011 Feb; 108(2):178-82. PubMed ID: 21253746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.